Effectiveness of deferred therapy with ganciclovir in renal allograft recipients with cytomegalovirus disease

MeSH terms

• Acute Disease
• Antiviral Agents / administration & dosage
• Antiviral Agents / therapeutic use*
• Cytomegalovirus / isolation & purification
• Cytomegalovirus Infections / diagnosis
• Cytomegalovirus Infections / drug therapy*
• Cytomegalovirus Infections / epidemiology
• Drug Administration Schedule
• Follow-Up Studies
• Ganciclovir / administration & dosage
• Ganciclovir / therapeutic use*
• Graft Rejection / epidemiology
• Graft Survival*
• Humans
• Incidence
• Kidney Transplantation / immunology
• Kidney Transplantation / mortality
• Kidney Transplantation / physiology*
• Polymerase Chain Reaction
• Postoperative Complications
• Retrospective Studies
• Risk Factors
• Survival Rate
• Time Factors